Cargando…

Treatment of refractory lupus nephritis using leflunomide: A prospective study

INTRODUCTION: The condition of refractory lupus nephritis (LN) negatively affects the prognosis and life expectancy of the patients, posing a challenge to manage in clinical. This interventional study evaluated the efficacy as well as safety of leflunomide in patients with refractory LN. METHODS: Tw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shuo, Chen, Yiran, Chen, Xin, Zhao, Yan, Zeng, Xiaofeng, Zhang, Fengchun, Wang, Li, Li, Mengtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065288/ https://www.ncbi.nlm.nih.gov/pubmed/37006280 http://dx.doi.org/10.3389/fimmu.2023.1133183

Ejemplares similares

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis
por: Cao, Heng, et al.
Publicado: (2015)

Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia
por: Zhang, Shuo, et al.
Publicado: (2021)

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
por: Yan, Qingran, et al.
Publicado: (2023)

CRAC Channel Controls the Differentiation of Pathogenic B Cells in Lupus Nephritis
por: Li, Xue, et al.
Publicado: (2021)

Leflunomide therapy for IgA vasculitis with nephritis in children
por: Hou, Ling, et al.
Publicado: (2021)

Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up
por: Fu, Qiong, et al.
Publicado: (2022)

A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus
por: Zhang, Shuo, et al.
Publicado: (2021)

Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
por: He, Jingquan, et al.
Publicado: (2022)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study
por: Zhang, Lifan, et al.
Publicado: (2023)

Mesangial cell: A hub in lupus nephritis
por: Liu, Mengdi, et al.
Publicado: (2022)

Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis
por: Chen, Shanshan, et al.
Publicado: (2023)

The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis
por: Chen, Yulan, et al.
Publicado: (2023)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus
por: Zhang, Yamei, et al.
Publicado: (2022)

Discovery of Novel Circulating Immune Complexes in Lupus Nephritis Using Immunoproteomics
por: Tang, Chenling, et al.
Publicado: (2022)

Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications
por: Li, Jicui, et al.
Publicado: (2022)

High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis
por: Ye, Xiaolan, et al.
Publicado: (2020)

Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity
por: Chen, Dandan, et al.
Publicado: (2022)

Ferroptosis of CD163(+) tissue-infiltrating macrophages and CD10(+) PC(+) epithelial cells in lupus nephritis
por: Cheng, Qi, et al.
Publicado: (2023)

Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study
por: Wang, Qiang, et al.
Publicado: (2021)

Glomerular Expression of S100A8 in Lupus Nephritis: An Integrated Bioinformatics Analysis
por: Qijiao, Wei, et al.
Publicado: (2022)

Relapsing polychondritis: focus on cardiac involvement
por: Yin, Ruxue, et al.
Publicado: (2023)

Management of refractory lupus nephritis: challenges and solutions
por: Yo, JH, et al.
Publicado: (2019)

Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis
por: Zhou, Xue, et al.
Publicado: (2022)

B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Erythematosus
por: Zhang, Huidi, et al.
Publicado: (2018)

Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study
por: Lu, Xinxia, et al.
Publicado: (2023)

Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort
por: Liu, Suying, et al.
Publicado: (2022)

Clusters of clinical and immunologic features in patients with bullous systemic lupus erythematosus: experience from a single-center cohort study in China
por: Qiao, Lin, et al.
Publicado: (2022)

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice
por: Hu, Lingzhen, et al.
Publicado: (2021)

Serological, fragmentomic, and epigenetic characteristics of cell-free DNA in patients with lupus nephritis
por: Wang, Fang, et al.
Publicado: (2022)

Elevated serum levels of human epididymis protein 4 in adult patients with proliferative lupus nephritis
por: Li, Liubing, et al.
Publicado: (2023)

Lupus nephritis in children – 10 years’ experience
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2016)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
por: Bejar, Jacob, et al.
Publicado: (2018)

Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
por: Gatto, Mariele, et al.
Publicado: (2019)

B Cell Subsets and Cellular Signatures and Disease Relapse in Lupus Nephritis
por: Yap, Desmond Y. H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0f1h9afugimqt2aghphjsuvlul